Abraar Karan

Last updated
Abraar Karan
NationalityAmerican
Alma mater Yale University (BA)

University of California Los Angeles (MD)

Harvard University (MPH)

London School of Hygiene and Tropical Medicine (DTM&H)
AwardsNMQF 40 Under 40 (2020)

STAT Wunderkind (2018)

Medtech Boston 40 Under 40 (2018)

Harvard Business School New Venture Competition (2018)
Scientific career
FieldsGlobal health
Institutions Brigham and Women's Hospital

Harvard Medical School

Stanford University

Abraar Karan is an American global health physician and researcher. He was active in the COVID-19 epidemic response in Massachusetts [1] and involved nationally through his contributions to lay press media platforms. He is a columnist [2] at the British Medical Journal , a contributor [3] at the National Public Radio, and regularly writes in the lay press.

Contents

Education

Karan attended Yale University, where he graduated with distinction in Political Science. During college, Karan worked in the Dominican Republic, Mexico, Honduras, Nicaragua, Uganda, and India on public health research focused on the links between poverty, structural violence, and health. [4] [5] He also studied as a Yale Journalism Scholar under former New York Times Executive Editor, Jill Abramson.

Karan was awarded a Yale Parker Huang Fellowship, which supported a year of research in Hyderabad and New Delhi, India, exploring the Stockholm Syndrome among female sex workers, as well as sex trafficking victims in red light districts. [6] Along with Dr. Nathan Hansen, Karan proposed the term “Sonagachi Syndrome” [7] to describe the psychological dependency that victims of sex trafficking at times display to their captors, [8] named after Sonagachi, India's largest red light district.

Medical and public health training

Karan earned his doctorate in medicine at the David Geffen School of Medicine at UCLA, where he served as Class President. During medical school, Karan worked at the United States CDC in Mozambique and at the Siriraj Hospital in Bangkok, Thailand. He was selected as a 2016 medical fellow at the Fellowships at Auschwitz for the Study of Medical Ethics. [9] [10]

He went on to earn an MPH in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health. During graduate school, with his college roommate Andrew Rothaus, Karan co-founded Hour72 insect repellent, [11] [5] for which the pair won the Harvard Business School's New Venture Competition, [12] and were finalists in the Harvard President's Challenge. [13]

Karan trained in internal medicine at the Brigham and Women's Hospital and Harvard Medical School, in the Hiatt Residency in Global Health Equity established by Dr. Howard Hiatt and Dr. Paul Farmer. Karan earned his Diploma in Tropical Medicine and Hygiene (DTM&H) from the London School of Hygiene and Tropical Medicine in 2019. He is an infectious diseases fellow and post-doctoral researcher at Stanford University. [14]

Journalism and writing

Karan is the co-editor of the book, Protecting the Health of the Poor: Social Movements in the Global South, [15] with ethicist Dr. Thomas Pogge. Karan went on to work as the editor on two global health works with the American Medical Association's Journal of Ethics. In 2016-17, Karan led the theme issue on international healthcare systems, [16] and in 2019-20 on pandemic response. [17]

Karan has written about neocolonialism in global health, and has been critical of the current global health enterprise. [18] [19] Karan has been a columnist at the British Medical Journal since January 2019. [2] He became a contributor to NPR during COVID-19, helping with weekly COVID-19 FAQs, [3] on NPR All Things Considered [20] [21] with Ari Shapiro, and NPR Weekend Edition. [22]

COVID-19 response

Karan was active in the Massachusetts COVID-19 epidemic response as a medical fellow working with Commissioner Monica Bharel in the Massachusetts Department of Public Health. [1] Karan was a member of the Crisis Standard of Care Committee, and also worked on the allocation of scarce resources in the state response, including ventilators and Remdesivir. [1]

Prior to the first COVID-19 surge, Karan wrote about the need for doctors to discuss code status with their high-risk patients in advance to plan for end-of-life care given high rates of ventilator deaths. [23] He was a proponent of the Black Lives Matter protests as being key to bringing attention toward the racial inequities in COVID-19 outcomes in the US. [24] [25] Karan wrote in the Washington Post that central isolation options were a key part of breaking chains of disease transmission after he noted that many of his patients were unable to safely isolate. [26] He opined against the early xenophobia against Asians; [27] in favor of a diverse range of expert voices in pandemic response; [28] and warned that stigma could obstruct the success of contact tracing efforts. [29]

Along with Dr. Ranu Dhillon and Sri Srikrishna, Karan advocated for the need for better masks at a population level early in the epidemic. [30] [31] Karan and Dhillon also penned op-eds warning against the reopening of professional sports given high levels of community transmission of COVID-19 at the time; [32] the need for smarter, targeted lockdowns in high-transmission counties; [33] the use of rapid antigen tests for epidemic control; [34] and the need for stronger public health outbreak investigations and contact tracing to understand why COVID-19 transmission was ongoing despite implemented control measures. [35] Karan warned about the potential for President Trump's COVID-19 case to be used to downplay the virus. [36] He wrote in his column in the British Medical Journal that physicians needed to take a stance in the 2020 United States election because "there is no talking about politics without talking about health." [37] Karan was critical of the Great Barrington Declaration and debated against one of its authors, Dr. Martin Kulldorff, on Democracy Now. [38] He spoke on the Zach Lowe ESPN podcast regarding Covid19 and the risk of spread in the NBA. [39] In late January 2021, he was quoted in a CNN interview with Sanjay Gupta that if all Americans wore N95 equivalent masks for four weeks, "This would stop the epidemic". [40]

Awards

Related Research Articles

<span class="mw-page-title-main">Pandemic</span> Widespread, often global, epidemic of severe infectious disease

A pandemic is an epidemic of an infectious disease that has spread across a large region, for instance multiple continents or worldwide, affecting a substantial number of individuals. Widespread endemic diseases with a stable number of infected individuals such as recurrences of seasonal influenza are generally excluded as they occur simultaneously in large regions of the globe rather than being spread worldwide.

<span class="mw-page-title-main">Peter Piot</span> Belgian microbiologist (born 1949)

Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.

<span class="mw-page-title-main">Kamran Abbasi</span> British physician and sports writer

Kamran Abbasi is the editor-in-chief of the British Medical Journal (BMJ), a physician, visiting professor at the Department of Primary Care and Public Health, Imperial College, London, editor of the Journal of the Royal Society of Medicine(JRSM), journalist, cricket writer and broadcaster, who contributed to the expansion of international editions of the BMJ and has argued that medicine cannot exist in a political void.

<span class="mw-page-title-main">Social distancing</span> Infection control technique by keeping a distance from each other

In public health, social distancing, also called physical distancing, is a set of non-pharmaceutical interventions or measures intended to prevent the spread of a contagious disease by maintaining a physical distance between people and reducing the number of times people come into close contact with each other. It usually involves keeping a certain distance from others and avoiding gathering together in large groups.

<span class="mw-page-title-main">Eric Feigl-Ding</span> American public health scientist

Eric Liang Feigl-Ding is an American public health scientist who is currently an epidemiologist and Chief of COVID Task Force at the New England Complex Systems Institute. He was formerly a faculty member and researcher at Harvard Medical School and Harvard T.H. Chan School of Public Health. He is also the Chief Health Economist for Microclinic International, and co-founder of the World Health Network. His research and advocacy have primarily focused on obesity, nutrition, cancer prevention, and biosecurity.

<span class="mw-page-title-main">Public health emergency of international concern</span> Formal declaration by the World Health Organization

A public health emergency of international concern is a formal declaration by the World Health Organization (WHO) of "an extraordinary event which is determined to constitute a public health risk to other States through the international spread of disease and to potentially require a coordinated international response", formulated when a situation arises that is "serious, sudden, unusual, or unexpected", which "carries implications for public health beyond the affected state's national border" and "may require immediate international action". Under the 2005 International Health Regulations (IHR), states have a legal duty to respond promptly to a PHEIC. The declaration is publicized by an IHR Emergency Committee (EC) of international experts, which was developed following the 2002–2004 SARS outbreak.

<span class="mw-page-title-main">Disease X</span> Placeholder infectious disease name from the WHO

Disease X is a placeholder name that was adopted by the World Health Organization (WHO) in February 2018 on their shortlist of blueprint priority diseases to represent a hypothetical, unknown pathogen that could cause a future epidemic. The WHO adopted the placeholder name to ensure that their planning was sufficiently flexible to adapt to an unknown pathogen. Director of the US National Institute of Allergy and Infectious Diseases Anthony Fauci stated that the concept of Disease X would encourage WHO projects to focus their research efforts on entire classes of viruses, instead of just individual strains, thus improving WHO capability to respond to unforeseen strains. In 2020, experts, including some of the WHO's own expert advisors, speculated that COVID-19, caused by the SARS-CoV-2 virus strain, met the requirements to be the first Disease X.

<span class="mw-page-title-main">Devi Sridhar</span> Global public health researcher

Devi Lalita Sridhar FRSE is an American public health researcher, who is both professor and chair of global public health at the University of Edinburgh, Scotland. Her research considers the effectiveness of public health interventions and how to improve developmental assistance for health. Sridhar directs the University of Edinburgh's Global Health Governance Programme which she established in 2014.

<span class="mw-page-title-main">COVID-19 pandemic in the United Kingdom</span> Ongoing viral pandemic

The COVID-19 pandemic in the United Kingdom is a part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the United Kingdom, it has resulted in 24,812,582 confirmed cases, and is associated with 232,112 deaths.

<span class="mw-page-title-main">Dale Fisher</span> Australian physician (born 1960)

Dale Andrew Fisher FRACP is an Australian physician who specialises in Infectious Diseases and is a Senior Consultant in the Division of Infectious Diseases at the National University Hospital, Singapore. He is also a professor of medicine at the Yong Loo Lin School of Medicine, National University of Singapore, the chair of the National Infection Prevention and Control Committee through the Ministry of Health, Singapore, and chair of the steering committee of the Global Outbreak Alert and Response Network hosted by the World Health Organization.

The Global Health Security Index is an assessment of global health security capabilities in 195 countries prepared by the Johns Hopkins Center for Health Security, the Nuclear Threat Initiative (NTI) and the Economist Intelligence Unit (EIU).

<span class="mw-page-title-main">Flattening the curve</span> Public health strategy

Flattening the curve is a public health strategy to slow down the spread of an epidemic, used against the SARS-CoV-2 virus during the early stages of the COVID-19 pandemic. The curve being flattened is the epidemic curve, a visual representation of the number of infected people needing health care over time. During an epidemic, a health care system can break down when the number of people infected exceeds the capability of the health care system's ability to take care of them. Flattening the curve means slowing the spread of the epidemic so that the peak number of people requiring care at a time is reduced, and the health care system does not exceed its capacity. Flattening the curve relies on mitigation techniques such as hand washing, use of face masks and social distancing.

<span class="mw-page-title-main">Nahid Bhadelia</span> Indian-American infectious diseases physician and researcher

Nahid Bhadelia is an American infectious-diseases physician, founding director of Center for Emerging Infectious Diseases Policy and Research (CEID), an associate director at National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University, and an associate professor at the Boston University School of Medicine. She currently serves as the Senior Policy Advisor for Global COVID-19 Response on the White House COVID-19 Response Team.

<span class="mw-page-title-main">Caitlin Rivers</span> American emerging infectious disease epidemiologist

Caitlin M. Rivers is an American epidemiologist who as Senior Scholar at the Johns Hopkins Center for Health Security and assistant professor at the Johns Hopkins Bloomberg School of Public Health, specializing on improving epidemic preparedness. Rivers is currently working on the American response to the COVID-19 pandemic with a focus on the incorporation of infectious disease modeling and forecasting into public health decision making.

Maimuna (Maia) Majumder is a computational epidemiologist and a faculty member at Harvard Medical School and Boston Children's Hospital's Computational Health Informatics Program (CHIP). She is currently working on modeling the spread of the COVID-19 pandemic.

Planning and preparing for pandemics has happened in countries and international organizations. The World Health Organization writes recommendations and guidelines, though there is no sustained mechanism to review countries' preparedness for epidemics and their rapid response abilities. National action depends on national governments. In 2005–2006, before the 2009 swine flu pandemic and during the decade following it, the governments in the United States, France, UK, and others managed strategic health equipment stocks, but they often reduced stocks after the 2009 pandemic in order to reduce costs.

<span class="mw-page-title-main">Public health mitigation of COVID-19</span> Measures to halt the spread of the respiratory disease among populations

Part of managing an infectious disease outbreak is trying to delay and decrease the epidemic peak, known as flattening the epidemic curve. This decreases the risk of health services being overwhelmed and provides more time for vaccines and treatments to be developed. Non-pharmaceutical interventions that may manage the outbreak include personal preventive measures such as hand hygiene, wearing face masks, and self-quarantine; community measures aimed at physical distancing such as closing schools and cancelling mass gathering events; community engagement to encourage acceptance and participation in such interventions; as well as environmental measures such surface cleaning. It has also been suggested that improving ventilation and managing exposure duration can reduce transmission.

Roopa Dhatt is an Indian American physician, an Assistant Professor and Internal Medicine Hospitalist at Georgetown University Medical Center, and at a community hospital, Washington, DC. In 2015 she co-founded Women in Global Health, which aims to reduce gender disparity among global health leaders, and subsequently became the organisation's Executive Director.

Madhukar Pai is an Indian medical doctor, academic, advocate, writer, and university professor. Pai's work is around global health, specifically advocacy for better treatment for tuberculosis with a focus on South Africa and India. Pai is the Canada Research Chair of Epidemiology and Global Health at McGill University.

References

  1. 1 2 3 "Brigham Resident Contributes to Statewide COVID-19 Response". Brigham Bulletin. 2020-07-09. Retrieved 2020-07-19.
  2. 1 2 "Abraar Karan Archives". The BMJ. Retrieved 2020-07-19.
  3. 1 2 "NPR Search : Abraar Karan". npr.org. Retrieved 2020-10-10.
  4. ↑ "Calabasas grad already making impact on world health scene". The Acorn. 2018-06-14. Retrieved 2020-07-19.
  5. 1 2 "A Better Insect Repellent". Harvard Public Health Magazine. 2020-05-29. Retrieved 2020-07-19.
  6. ↑ "The Surprising Wishes Of India's Sex Workers". NPR.org. Retrieved 2020-07-19.
  7. ↑ Karan, Abraar; Hansen, Nathan (2018-02-06). "Does the Stockholm Syndrome affect female sex workers? The case for a "Sonagachi Syndrome"". BMC International Health and Human Rights. 18 (1): 10. doi: 10.1186/s12914-018-0148-4 . ISSN   1472-698X. PMC   5802051 . PMID   29409491.
  8. ↑ "Stockholm Syndrome in the Pimp-Victim Relationship". New York Times. 3 May 2012.
  9. ↑ "Fellows By Year | FASPE" . Retrieved 2020-07-19.
  10. ↑ "Local alumni chosen to study in European ethics program". The Acorn. 2016-04-21. Retrieved 2020-07-23.
  11. ↑ Belli, Brita (2018-05-04). "Former Yale roommates win $75K grand prize at Harvard to combat disease". YaleNews. Retrieved 2020-07-19.
  12. ↑ "Three-day mosquito repellent takes top prize at biz school competition". News. 2018-04-25. Retrieved 2020-07-19.
  13. ↑ "Finalists Named in Annual President's Innovation Challenge". Harvard Innovation Labs. Retrieved 2020-07-19.
  14. ↑ "Abraar Karan, MD MPH DTM&H's Profile | Stanford Profiles". profiles.stanford.edu. Retrieved 2023-01-15.
  15. ↑ Protecting the Health of the Poor. Archived from the original on 2020-07-19. Retrieved 2020-07-19.
  16. ↑ Karan, Abraar (2016-07-01). "Building Ethical Global Health Care Systems". AMA Journal of Ethics. 18 (7): 661–664. doi: 10.1001/journalofethics.2016.18.7.fred1-1607 . ISSN   2376-6980.
  17. ↑ "Culture, Context, and Epidemic Containment". AMA Journal of Ethics. 22 (1): 1–65. 2020-01-01. ISSN   2376-6980.
  18. ↑ "Opinion: It's Time To End The Colonial Mindset In Global Health". NPR.org. Retrieved 2020-07-19.
  19. ↑ "OPINION: The Ghosts Of Colonialism Are Haunting The World's Response To The Pandemic". NPR.org. Retrieved 2020-07-19.
  20. ↑ "Physician Helps Listeners Make Choices". NPR.org. Retrieved 2020-07-19.
  21. ↑ "Global Health Expert Answers The Most Common Coronavirus Questions". NPR.org. Retrieved 2020-07-19.
  22. ↑ "Treating COVID-19: What We Know Now". NPR.org. Retrieved 2020-07-19.
  23. ↑ "If You Get Critically Ill With COVID-19, How Far Should Doctors Go To Keep You Alive?". wbur.org. Retrieved 2020-07-19.
  24. ↑ Diamond, Dan. "Suddenly, Public Health Officials Say Social Justice Matters More Than Social Distance". POLITICO. Retrieved 2020-07-19.
  25. ↑ Karan, Abraar; Katz, Ingrid (2020-06-09). "There is no stopping covid-19 without stopping racism". BMJ. 369: m2244. doi: 10.1136/bmj.m2244 . ISSN   1756-1833. PMID   32518097. S2CID   219542161.
  26. ↑ "Perspective | If you get covid-19, leaving your house may be the best way to protect your family". Washington Post. Retrieved 2020-07-19.
  27. ↑ "Abraar Karan: Coronavirus—containing the parallel epidemics of xenophobia and misinformation". The BMJ. 2020-01-31. Retrieved 2020-07-19.
  28. ↑ "Abraar Karan: Covid-19—on trust, experts, and the brilliance of everyday people". The BMJ. 2020-03-26. Retrieved 2020-07-19.
  29. ↑ "Stigma is making the COVID-19 pandemic more invisible - The Boston Globe". BostonGlobe.com. Archived from the original on 2020-11-30. Retrieved 2021-01-27.
  30. ↑ Dhillon, Ranu S.; Karan, Abraar; Beier, David; Sullivan, Andrew; Chowell, Gerardo; Chowell, Diego; Srikrishna, Devabhaktuni (2020-05-01). "A Plan to Safely Reopen the U.S. Despite Inadequate Testing". Harvard Business Review. ISSN   0017-8012 . Retrieved 2020-07-19.
  31. ↑ Dhillon, Ranu S.; Karan, Abraar; Beier, David; Srikrishna, Devabhaktuni (2020-06-18). "We Need Better Masks". Harvard Business Review. ISSN   0017-8012 . Retrieved 2020-07-19.
  32. ↑ Karan, Abraar; Dhillon, Ranu. "Perspective | Sports can't restart safely right now". Washington Post. Retrieved 2020-07-19.
  33. ↑ Dhillon, Ranu S.; Karan, Abraar (2020-08-12). "The U.S. Needs Smarter Lockdowns. Now". Harvard Business Review. ISSN   0017-8012 . Retrieved 2020-08-21.
  34. ↑ Dhillon, Ranu S.; Karan, Abraar; Srikrishna, Sri. "Perspective | We could control the coronavirus by winter if we start using rapid tests". Washington Post. Retrieved 2020-08-21.
  35. ↑ Dhillon, Ranu S.; Karan, Abraar. "Perspective | We can't stop covid-19 if we don't know where and why it's spreading". Washington Post. ISSN   0190-8286 . Retrieved 2020-10-10.
  36. ↑ Karan, Abraar. "Perspective | Trump's case should not change how we think about covid-19". Washington Post. ISSN   0190-8286 . Retrieved 2020-10-10.
  37. ↑ "Abraar Karan: Politics and public health in America—taking a stand for what is right". The BMJ. 2020-10-09. Retrieved 2020-10-10.
  38. ↑ "Herd Immunity: Is It a More Compassionate Approach or Will It Lead to Death or Illness for Millions?". Democracy Now!. Retrieved 2020-10-16.
  39. ↑ "ESPN Lowe Podcast". Archived from the original on 2021-01-12.
  40. ↑ Enriquez, Keri. "The face mask that could end the pandemic". CNN. Retrieved 2021-01-26.
  41. ↑ "50 Experts to Trust in a Pandemic". Medium. 2020-09-18. Retrieved 2020-10-10.
  42. ↑ "Abraar Karan, MD, MPH, DTM&H". The National Minority Quality Forum. Retrieved 2020-07-19.
  43. ↑ "Meet the 2018 STAT Wunderkinds". STAT. Retrieved 2020-07-19.
  44. ↑ "Announcing the 2018 MedTech Boston 40 Under 40 Healthcare Innovators!". MedTech Boston. 2018-09-18. Retrieved 2020-07-19.
  45. ↑ "Harvard Business School Names Winners of 21st New Venture Competition at Finale - News - Harvard Business School". hbs.edu. Retrieved 2020-07-19.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.